Hunniwell Lake Ventures

List of Open COVID-19 Grants

With the world singularly united in efforts to solve the challenges presented by COVID-19, there has been an international call for research and innovations to fight the pandemic. We have gathered a list of currently active COVID-19 grants, sourced from governments and organizations from around the globe, seeking a variety of different solutions and reliefs. This list has been sorted by deadline (before July 1, after July 1, Indefinite, and Unknown), and has noted the geographic restrictions – if any – placed on each grant. A general categorization of the grant’s request, as well as their available funding has been provided as well. We would like to encourage readers to bring to our attention additional grants to be added to our list, or correct any present errors by emailing us at comms@hunniwell.com. Picture courtesy of Shutterstock. 

Please click the grant name to reach its website for more information. This is an ongoing list of grants focused on supporting COVID-19 efforts and will be continually updated. Please reach out to comms@hunniwell.com to contribute to this list or would like more information. 

Name of GrantType of Activity SupportedGrantorGrantor ClassificationDeadline Total funding availableApplicant Geographic RestrictionsEstimated funding per grant
Bench Testing Therapeutic/Indication Pairing StrategiesPharmaNational Center for Advancing Translational PAR-17-465 Sciences/NIH/DHHSGovernment2020-06-26 Not AvailableUS (foreign components allowed, foreign institutions are not)700000
RFA-AI-20-028 -- Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)PharmaNational Institute of Allergy and Infectious
Diseases/NIH/DHHS
Government2020-06-29 10500000US$750,000 a year for up to 5 years
COVID-19 ChallengesOther BiotechDepartment of National Defence (DND)Government2020-06-23 11116792.95Canada$200,000 for Phase I, $1,000,000 for Phase II (CAD)
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)Other BiotechNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Government2020-06-16 Not AvailableUS$400000 over 3 years
NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional)All-typesNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Government2020-06-16 Not Available$275,000 over 2 years
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)All-typesNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Government2020-06-16 Not Available50000
Achieving an unprecedented acceleration of vaccine development and global manufacturing capacity to prevent COVID-19PharmaCoalition for Epidemic Preparedness Innovations (CEPI)Int'l Organization2020-06-30 Not AvailableSwitzerlandCovers expenses
The COVID-19 Detect & Protect ChallengeAll-typesThe United Nations Development Programs Centre for Technology, Innovation and Sustainable Development, Hackster.ioInt'l Organization2020-06-30 25000$500 or $1500 depending on the award
AWS Diagnostic Development Initiative (DDI)DiagnosticsAmazon Web ServicesPrivate2020-06-20 20000000In-kind
Special call for proposals: Fight SARS-CoV-2All-typesDIM ELICITPrivate2020-06-30 €10,000,000 budgetIle de France region€15,000 for running/staff and/or €30,000 for equipment totalling €45,000
ATS/GSK Research Grant in COVID-19Academic ResearchAmerican Thoracic Society (ATS), GlaxoSmithKlinePrivate2020-06-23 10000050000
Scientist Development AwardAll-typesRheumatology Research FoundationPrivate2020-06-01 for Letter of Intent
2020-07-01 for Application
Not Available225000
Investigator AwardAll-typesRheumatology Research FoundationPrivate2020-06-01 for Letter of Intent
2020-07-01 for Application
Not Available375000
Innovative Research AwardAll-typesRheumatology Research FoundationPrivate2020-06-01 for Letter of Intent
2020-07-01 for Application
Not Available400000
Innovative Research Award for Community PractitionersAll-typesRheumatology Research FoundationPrivate2020-06-01 for Letter of Intent
2020-08-03 for Application
Not Available400000
Elevate PrizeAll-typesElevate Prize Foundation, MIT SolveUniversity2020-06-29 5000000300000
Health Security and Pandemics ChallengeAll-typesMIT SolveUniversity2020-06-18 Not AvailableUS10000
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)All-typesNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Government2020-07-07 Not AvailableUS$252,131 for Phase I
$1,680,879 for Phase II
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not AllowedAll-typesNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Government2020-07-07 Not AvailableUS$252,131 for Phase I
$1,680,879 for Phase II
Medical Robotics for Contagious Diseases ChallengeOther BiotechEPSRC UK-Robotics Autonomous Systems (UK-RAS) NetworkGovernment2020-09-30 Not AvailableUK£15,000
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)PharmaDepartment of Health & Human ServicesGovernment2020-10-31 Not AvailableUSNot available
RFP--AMENDMENT--Special Notice for Innovative Commercial Products in Support of CORONAVIRUS (COVID-19) ResponseDiagnosticsDepartment of Homeland SecurityGovernment2020-08-31 Not AvailableUSNot available, not guaranteed
Ecology and Evolution of Infectious Diseases (EEID)MonitoringNational Science FoundationGovernment2020-11-18 24000000US2400000
RFP - CSO COVID-19 ResponseAll-typesDepartment of the Air ForceGovernment2020-09-30 Not AvailableUSNot available
Prototype Development to Combat COVID-19All-typesDOD - Department of the Army, Medical Technology Enterprise ConsortiumGovernment2020 - Projected mid-202020000000US4000000
Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 (NSF 20-065)All-typesNational Science FoundationGovernment2020-09-03,
2020-09-04,
2020-12-03
2500000000US$256,000 until Phase I award, then up to $1,500,000 additional funding
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)All-typesDepartment of Health & Human ServicesGovernment2020-10-31 Not SpecifiedUSNot available
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)PharmaNational Institute of Allergy and Infectious Diseases/NIH/DHHSGovernment2020-09-03 1000000USThe combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
COVID-19 Regional Genomics InitiativeAll-typesGenomeCanadaGovernment2022-06-30 1111679.29Canada$250,000 (CAD)
Call for Multidisciplinary Research into Epidemics and PandemicsAll-typesDeutsche Forschungsgemeinschaft (DFG)Government2020-07-01 for Letters of Intent, 2020-09-01 for proposalsNot AvailableGermanyCovers expenses
Urgent Funding for Research into Humanitarian Crises Like Epidemics and PandemicsAll-typesAustrian Science Fund (FWF)Government2020-09-30 32884550AustriaCovers expenses (on average about €275,000)
Call for projects RA-COVID-19MonitoringAgence Nationale de la Recherche (ANR)Government2020-10-28 17009250France150000
Global Effort on COVID-19 Health Research (GECO)MonitoringNational Institute for Health Research (NIHR), UKGovernment2020-09-28 Not AvailableUK and low and middle-income countries(LMIC)£1,000,000
COVID-19 Rapid Response Rolling CallAll-typesMedical Research Council UK, UKRIGovernment2021-04-01 No limit setUKCovers expenses
COVID-19 R&D FundPharmaThe Malta Council for Science and TechnologyGovernment2020-12-31 6009935MaltaCovers expenses
NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)All-typesNIHGovernment2020-09-30 30000000USCovers expenses
NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional)All-typesNIHGovernment2030-09-04 30000000US250000
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of ExcellencePharmaNational Cancer Institute (NCI)Government2020-07-20 19000000USeither $1,500,000 or $500,000 depending on the type
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research NetworkAll-typesNational Institute of Dental and Craniofacial Research (NIDCR)Government2020-11-02 NoneUSIn-kind
NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)All-typesNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Government2020-09-05,
2021-01-05
Not AvailableUS$225,000 for Phase I
$1,500,000 for Phase I
Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)Other DevicesNational Center for Advancing Translational Sciences (NCATS)Government2020-07-10,
2020-11-09,
2021-03-08
2021-07-09
Not AvailableUS$750,000 a year
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)Other DevicesNational Center for Advancing Translational Sciences (NCATS)Government2020-07-10,
2020-11-09,
2021-03-08
2021-07-09
Not AvailableUS$275,000 over 2 years
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)Other DevicesNational Center for Advancing Translational Sciences (NCATS)Government2020-09-25 9000000USFor clinical projects, no more than $750,000 direct costs annual budget should be requested. For non-clinical projects, no more than $400,000 direct costs annual budget should be requested.
Fondo Supera COVID-19All-typesBanco Santander and Spanish National Research Council (CSIC), SpainGovernment, Private and University2020-12-18 5669750SpainCovers expenses
AMable Open Call for Solution Ideas (COVID-19)All-typesAMableInt'l Organization2020-10-01 396882.5Europe€10000 per challenge set, up to €60,000
Research Grant for Pandemic PreparednessAll-typesMerck KGaAPrivate2020-08-31 Not Available1500000
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)PharmaDepartment of Health & Human ServicesGovernmentRolling SubmissionNot availableUS275000
RFP -- AMENDMENT --- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency AnnouncementAll-typesDepartment of Health & Human ServicesGovernmentContinuous750000USNot available
Dear Colleague Letter--Coronavirus Disease 2019 (COVID-19)PharmaDepartment of EnergyGovernmentContinuous SubmissionNot SpecifiedUSIn-kind
R$ 30 milhões para pesquisa sobre o Covid-19PharmaFAPERJ and the State of Rio de Janeiro, BrazilGovernmentContinuous$30,000,000 (Brazilian Reals)BrazilCovers expenses
Special Call for COVID-19 ProjectsPharmaCalifornia's Institute for Regenerative Medicine (CIRM)Government2020-05-07, new deadline every 2 weeks following5000000Clinical trial $750,000
Late stage preclinical $400,000
Translational $350,000
Discovery $150,000
Fast-Track Program for COVID-19 Test Development and Distribution
Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing
DiagnosticsNational Institute of Biomedical Imaging and Bioengineering (NIBIB)GovernmentRolling Basis500000000Phase 0: $25,000
Phase 1: $500,000 - < $10,000,000
Phase 2: $10,000,00 +
SARS-COV-2 Diagnostics: Performance DataOther DevicesFoundation for Innovative New Diagnostics (FIND)NGORolling BasisNot AvailableNot available
Emergency COVID-19 Research Seed FundingAll-typesUniversity of CaliforniaUniversityContinuous until funding expires2000000California25000
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)PharmaNational Institutes of Health/DHSSGovernmentNone PostedNot AvailableUSNot available
Expedited, Rapid Access Call for COVID-19 ResearchPharmaArgonne National LaboratoryGovernmentNone PostedNot AvailableUSIn-kind
COVID-19 Research SupportPharmaBrookhaven National LaboratoryGovernmentNone PostedNot AvailableUSIn-kind
Notice of Information: Contributing to the Global COVD-19 Crisis response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the CrisisPharmaNational Institutes of Health/DHSSGovernmentNone PostedNot AvailableUSNot available
Rapid Access for COVID-19 ResearchPharmaOak Ridge National LaboratoryGovernmentNone PostedNot AvailableIn-kind
COVID-19 Telehealth ProgramTelehealthFederal Communications CommissionGovernmentNone Posted200000000US1000000
Priority Access Call for Work on Combating COVID-19PharmaPaul Scherrer Institut (PSI) / Swiss Light Source (SLS) / SwissFELGovernmentNone PostedNot AvailableIn-kind
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)All-typesNational Institutes of Health (multiple ICs)GovernmentVaries by ICApplication budgets not limitedNot available
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)PharmaNational Institutes of Health/DHHSGovernmentVaries by ICNot AvailableUSApplication budgets not limited
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)PharmaNational Institutes of Health/DHHSGovernmentVaries by ICNot AvailableUSApplication budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project.
SOLICITUD URGENTE DE EXPRESIONES DE INTERÉS PARA LA FINANCIACIÓN EXTRAORDINARIA DE PROYECTOS DE INVESTIGACIÓN SOBRE EL SARS-COV-2 Y LA ENFERMEDAD COVID-19All-typesSpanish Instituto de Salud Carlos III (ISCIII)GovernmentNone Posted27214800Spain
COVID-19 Rapid ResponseAll-typesScience Foundation Ireland, Enterprise Ireland, IDA IrelandGovernmentNone PostedIrelandCovers expenses
COVID-19 HPC ConsortiumAll-typesWhite House Office of Science and Technology Policy, the U.S. Department of Energy and IBMGovernmentNone PostedNot AvailableIn-kind
Research and innovation ideas to address Covid-19TelehealthArts and Humanities Research Council, UK / UKRIGovernmentNone PostedNot AvailableCovers 80% of expenses
Rapid Access Call for Octopus Facility Proposals: SARS-CoV-2PharmaCentral Laser Facility, Science and Technology Facilities CouncilGovernmentNone PostedNot AvailableUKIn-kind
NRC Pandemic Response Challenge ProgramPharma, Diagnosis or TelehealthNational Research Council of Canada (NRC)GovernmentNone Posted11116792.95CanadaCovers expenses
Biomanufacturing capacity at Royalmount: NRC Human Health Therapeutics Research CentrePharmaHuman Healths Therapeutic Research CentreGovernmentNone Posted11116792.95CanadaIn-kind
2020 COVID-19 FlexGrantsOther BiotechWest Coast Consortium for Technology & Innovation in PediatricsGovernmentNone PostedNot AvailableUS15000
ICESCO Prize for Fighting Against CoronavirusPharmaIslamic World Education, Scientific, and Cultural OrganizationInt'l OrganizationNone Posted200000Morocco200000
Deuteration & Macromolecular Crystallisation (DEMAX) COVID-19 related Research ProjectsPharmaEuropean Spallation SourceInt'l OrganizationNone PostedNot AvailableIn-kind
Fast Track Call for Requests for Computing ResourcesAll-typesPartnership for Advanced Computing in Europe (PRACE)Int'l OrganizationNone PostedEuropeIn-kind
COVID-19 Fast Track AccessPharmaCentral European Research Infrastructure Consortium (CERIC)Int'l OrganizationNone PostedIn-kind
ICESCO Prize for Fighting Novel Coronavirus (Covid-19)PharmaIslamic World Educational, Scientific and Cultural Organization (ICESCO)Int'l OrganizationNone Posted200000200000
Covid-19 scientific researchAll-typesEuropean Synchrotron Radiation Facility (ESRF)Int'l OrganizationNone PostedNot AvailableIn-kind
Competitive Fund for Peace and RecoveryMonitoringInnovations for Poverty Action (IPA)NGOSee website for deadlines and how to applyNot AvailableNo high income countries, focus on UK Department for International Development (DFID) priority countries50000
Get funding for ideas that address COVID-19All-typesUK Research and Innovation (UKRI)NGONone PostedNo limit setUKCovers 80% of expenses
COVID-19 Young Leaders FundAll-typesOne Young WorldNGONot AvailableNot Available6000
Access to Platform for Partner COVID-19 ProjectsAll-typesGinkgo BioworksPrivateNone Posted25000000USIn-kind
COVID-19 Vaccine Development AwardPharmaMMS Holdings Inc.PrivateNone Posted1000000In-kind
Ferring COVID-19 Investigational GrantsMonitoringFerring PharmaceuticalsPrivateNone PostedNot Available25000
PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Dissemination and Implementation AwardsOther DevicesPatient-Centered Outcomes Research Institute (PCORI)PrivateNone PostedNot AvailableUS, foreign companies that demonstrate benefit to US healthcare/citizens500000
PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research ProjectsOther DevicesPatient-Centered Outcomes Research Institute (PCORI)PrivateNone PostedNot AvailableUS, foreign companies that demonstrate benefit to US healthcare/citizens500000
PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement AwardsOther DevicesPatient-Centered Outcomes Research Institute (PCORI)PrivateNone PostedNot AvailableUS, foreign companies that demonstrate benefit to US healthcare/citizens150000
The COVID-19 Therapeutics AcceleratorPharmaWellcome, Bill & Melinda Gates Foundation and MastercardPrivateNone Posted125000000Three posted examples all have $20,000,000 grants
Novartis COVID-19 Response FundOther DevicesNovartisPrivateNone Posted200000001000000
Labguru Pro-bono COVID-19 ProgrammePharmaBioDataPrivateNone Posted1000000In-kind
PharmaCOVID-19 Early Treatment Fund (CETF)PrivateNone Posted30000000<$1,000,000, past grants awarded average $300,000